Author

F.-X. Mahon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Nougairede· 1 shared A. Trinh· 1 shared B. Ghesquiere· 1 shared B. Quesnel· 1 shared B. Turcq· 1 shared C. Solas· 1 shared D. Bouscary· 1 shared D. Malvy· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Nougairede

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2

F. Touret, J.-S. Driouich, M. Cochin, P. R. Petit, M. Gilles, K. Barthelemy, G. Moureau, F.-X. MAHON, D. Malvy, C. Solas, X. de Lamballerie, A. Nougairede

This study evaluates Imatinib's antiviral potential against SARS-CoV-2 in vitro and in vivo, finding it ineffective in key models despite plasma and lung concentrations.

bioRxiv · Nov 17, 2020Microbiology

ANTIMETABOLIC COOPERATIVITY WITH THE CLINICALLY APPROVED KIDROLASE AND TYROSINE KINASE INHIBITORS TO ERADICATE CML STEM CELLS

A. Trinh, R. Khamari, Q. Fovez, F.-X. Mahon, B. Turcq, D. Bouscary, P. Maboudou, M. Joncquel, V. Coiteux, N. Germain, W. Laine, S. Dekiouk, B. Ghesquiere, T. Idziorek, B. Quesnel, , P. Marchetti

This study shows that combining tyrosine kinase inhibitors with Kidrolase targets glutamine metabolism and enhances CML stem cell eradication.

bioRxiv · Sep 21, 2020 · PreprintCancer Biology